SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Brian Thomas Hertzog who wrote (5356)9/21/1998 11:40:00 AM
From: Oliver & Co  Respond to of 6136
 
My broker told me that a small firm in Wall Street changed their ratings in AGPH last week from Hold to Buy.
JLL



To: Brian Thomas Hertzog who wrote (5356)9/21/1998 12:53:00 PM
From: jake burns  Read Replies (1) | Respond to of 6136
 
Perhaps they will be filing an NDA for REMUNE based on the Valentine data. That's all I can think of. Or it could just be more short covering for both stocks...each was under attack by shorts, and buying breeds more buying, as the shorts have to scramble to lock in profits.